Cresset Announces Appointment of David Bardsley as Sales Director
News Aug 27, 2012
Cresset BioMolecular Discovery has announced the appointment of Dr David Bardsley to the newly created role of Sales Director at Cresset Group.
David joins Cresset from Synergy Health Plc where, as Sales Director of the Healthcare Solutions division, he was responsible for the organization delivering product solutions to healthcare professionals and institutions.
“This new appointment marks Cresset’s commitment to ensuring companies have the right channels to access software tools and consulting services which are able to streamline their discovery process and tighten their IP position” said Rob Scoffin, Chief Executive Officer of Cresset.
“I am pleased to be joining Cresset BioMolecular Discovery at such an exciting time in their growth strategy. Cresset’s solutions and services have proven successful for many clients and this success can be duplicated to parallel markets and expanded geographies” said David.
David has extensive knowledge in software and technology solutions, with more than twenty years of commercial experience in the scientific market.
Prior to Cresset, David was responsible for business development and strategic commercial growth, with both Symyx Technologies and CambridgeSoft.
David has a PhD and BSc in Microbiology from the University of Wales Cardiff.
Can You Eat Cells? Computer Model Predicts Organisms that Use PhagocytosisNews
A computer model developed by Museum researchers may provide new insight into the origins of phagocytosis, the process by which single-celled organisms “eat” other cells as a means of absorbing nutrients or eliminating pathogens.READ MORE
Susan Audino Joins CloudLIMS’ Scientific Advisory BoardNews
Dr. Susan Audino, Chair of the Cannabis Working Group at AOAC International, has joined the Scientific Advisory Board at CloudLIMS, which specialises in data management solutions for cannabis testing laboratories.READ MORE